GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ)
$0.739 0.0373 (5.3157%)
Analysed GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ) News Sources
Galmed Announces a Collaboration Agreement with Tel Aviv University to Evaluate its SCD1 inhibitor, Aramchol, as a Targeted Therapy for Metastatic Brain Cancers
14-04-2026
yahoo.com
Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol
09-04-2026
yahoo.com
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
31-03-2026
yahoo.com
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification
30-01-2026
yahoo.com
Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting
08-12-2025
yahoo.com
Galmed Announces Grant of New Use Patents for the combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra (Resmetirom) for MASH
04-12-2025
yahoo.com
Galmed Issues CEO Letter to Shareholders
01-12-2025
yahoo.com
Galmed Pharmaceuticals: Q3 Earnings Snapshot
26-11-2025
yahoo.com
Galmed Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
26-11-2025
yahoo.com
Galmed Announces Meaningful Top Line Results from AM-001 Study of Aramchol Meglumine
18-11-2025
yahoo.com
What is the current price of GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ)?
The current price of GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ) is $0.739.
GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ) absolute price change since previous trading day?
The absolute price change of GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ) since the previous trading day is $0.0373.
GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ) percentage price change since previous trading day?
The percentage price change of GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ) since the previous trading day is 5.3157%.
What is the most recent average sentiment score for GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ)?
The most recent average sentiment score for GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ)?
The most recent sentiment for GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ) is .
SEC-8K** Filing Available For GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.